Chung Y., de Greeff A., Shennan A., 2009; 28: 348-59.
To assess the accuracy and patient compliance in using a novel home blood pressure monitoring device in high-risk pregnancy.
The device achieved a mean difference ± SD of 0.4 ± 7.3/ −0.4 ± 5.5 mmHg (pregnancy) and −2.6 ± 7.0/0.8 ± 4.4 mmHg (preeclampsia) for systolic/ diastolic pressure. Eighty-one percent of women did at least 6 measurements/day and all women did at least 2 measurements/week.
The Microlife WatchBP Home is accurate for use in pregnancy and increases surveillance in compliant patients.
Contact customer support if you would like our friendly agents to help you resolve your issues.find support